|
LIG1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | <1E-12 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.62636570877339E-12 |
| Normal-vs-Stage2 |
2.359700E-04 |
| Normal-vs-Stage3 |
2.1226999999957E-06 |
| Normal-vs-Stage4 |
2.823400E-03 |
| Stage1-vs-Stage2 |
6.025800E-01 |
| Stage1-vs-Stage3 |
7.265400E-01 |
| Stage1-vs-Stage4 |
2.078100E-03 |
| Stage2-vs-Stage3 |
8.449800E-01 |
| Stage2-vs-Stage4 |
7.724400E-02 |
| Stage3-vs-Stage4 |
2.659800E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
<1E-12 |
| Normal-vs-AfricanAmerican |
6.89849999346848E-09 |
| Normal-vs-Asian |
7.107800E-02 |
| Caucasian-vs-AfricanAmerican |
1.983830E-01 |
| Caucasian-vs-Asian |
9.510200E-01 |
| AfricanAmerican-vs-Asian |
6.907600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.62458935193399E-12 |
| Normal-vs-Female |
2.4757973449141E-14 |
| Male-vs-Female |
1.362200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
3.16970000246997E-08 |
| Normal-vs-Extreme_Weight |
6.17960127513584E-11 |
| Normal-vs-Obese |
6.59239329792172E-12 |
| Normal-vs-Extreme_Obese |
5.509900E-02 |
| Normal_Weight-vs-Extreme_Weight |
7.772000E-01 |
| Normal_Weight-vs-Obese |
3.203400E-01 |
| Normal_Weight-vs-Extreme_Obese |
1.871400E-01 |
| Extreme_Weight-vs-Obese |
1.439410E-01 |
| Extreme_Weight-vs-Extreme_Obese |
2.415400E-01 |
| Obese-vs-Extreme_Obese |
6.959500E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.42209999999909E-05 |
| Normal-vs-Age(41-60Yrs) |
1.62436730732907E-12 |
| Normal-vs-Age(61-80Yrs) |
1.74971148680925E-12 |
| Normal-vs-Age(81-100Yrs) |
2.715900E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.998000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.055250E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.798000E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.179560E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.140840E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.436000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.62447832963153E-12 |
| Normal-VS-Type2 PRCC |
5.98069999999673E-05 |
| Normal-VS-KIRP CIMP |
8.601500E-03 |
| Normal-VS-Unclassified PRCC |
1.85510000028088E-07 |
| Type1 PRCC-VS-Type2 PRCC |
2.00039984576961E-10 |
| Type1 PRCC-VS-KIRP CIMP |
3.245600E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
1.561030E-01 |
| Type2 PRCC-VS-KIRP CIMP |
7.095600E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
2.103300E-03 |
| KIRP CIMP-VS-Unclassified PRCC |
8.656000E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.33289999540531E-08 |
| Normal-vs-N1 |
2.763300E-04 |
| Normal-vs-N2 |
1.894840E-01 |
| N0-vs-N1 |
3.761000E-01 |
| N0-vs-N2 |
8.848800E-01 |
| N1-vs-N2 |
6.586600E-01 |
|
|
